Vaginal colonization with Candida spp. in human immunodeficiency virus - Infected women: A cohort study

International Journal of STD and AIDS

Volumn 17, Issue 4, 2006, Pages 260-266

  Beltrame, Anna ^a,b   Matteelli, Alberto ^b   Carvalho, Anna Cristina C ^b   Saleri, Nuccia ^b   Casalini, Caterina ^b   Capone, Susanna ^b   Patroni, Andrea ^b   Manfrin, Maria ^b   Carosi, Giampiero ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

C. albicans; Gynaecological disorders; HIV infected women; Vaginal candidiasis

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ADULT; ARTICLE; CANDIDA; CD4+ CD25+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNGAL COLONIZATION; FUNGUS CULTURE; GYNECOLOGIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SCREENING; SEXUALLY TRANSMITTED DISEASE; TERTIARY HEALTH CARE; VAGINA CANDIDIASIS; VAGINITIS; VIRUS LOAD;

ADULT; CANDIDIASIS, VULVOVAGINAL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; ITALY; LONGITUDINAL STUDIES; MASS SCREENING; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; VIRAL LOAD; WOMEN'S HEALTH;

EID: 33645536473     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646206776253435     Document Type: Article

References (26)

1. Spinillo A, Michelone G, Cavanna C, et al. Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive womem. Genitourin Med 1994;70:268-72
2. Duerr A, Sierra MF, Feldman J, et al. Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women. Obstet Gynecol 1997;90:252-6
3. Burns DN, Tuomala R, Chang BH, et al. Vaginal colonization or infection with Candida albicans in human immunodeficiency virus-infected women during pregnancy and during the postpartum period. Clin Infect Dis 1997;24:201-10
4. Schuman P, Sobel JD, Ohmit SE, et al. Mucosal candidal colonization and candidiasis in women with or at risk for Human Immunodeficiency Virus Infection. Clin Infect Dis 1998;27:1161-7
5. Sobel JD, Ohmit SE, Schuman P, et al. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from Human Immunodeficiency Virus (HIV) - seropositive and at - risk HIV - seronegative women. J Infect Dis 2001;183:286-93
6. Sobel JD. Vulvovaginal candidiasis: a comparison of HIV - positive and - negative women. Int J STD AIDS 2002;13:358-62
7. Duerr A, Heilig CM, Meikle SF, et al. Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: risk factors and severity. Obstet Gynecol 2003;101:548-56
8. Iman N, Carpenter CC, Mayer KH, et al. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990;89:142-6
9. Van Benthem BHB, Prins M, Larsen C, et al. Sexually transmitted infections in European HIV-infected women: incident in relation to time from infection. AIDS 2000;14:595-603
10. Vazquez JA, Sobel JD, Peng G, et al. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole: the emergence of Candida glabrata. Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA). Clin Infect Dis 1999;28:1025-31
11. De Bernardis F, Mondello F, Scaravelli G. High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected women. J Clin Microbiol 1999;37:1376-80
12. Centers for Diseases Control and Prevention. 1993 revised classification system for HIV infection and expandd surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-15
13. Rhoads JL, Wright DC, Redfield RR, Burke DS. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987;257:3105-7
14. Clark RA, Blakley SA, Rice J, Brandon W. Predictors of HIV progression in women. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:43-50
15. White MH. Is vulvovaginal candidiasis an AIDS-related illness ? Clin Infect Dis 1996;22(Suppl 2):S124-7
16. Gottfredsson M, Cox GM, Indridason OS, et al. Association of plasma levels of Human Immunodeficiency Virus Type 1 RNA and oropharyngeal Candida colonization. J Infect Dis 1999;180:534-7
17. Anzala AO, Simonsen JN, Kimani J, et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J Infect Dis 2000;182:459-66
18. Cassone A, Tacconelli E, De Bernardis F, et al. Antiretroviral therapy with protease inhibitors has an early, immune-reconstitution independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J Infect Dis 2002;185:188-95
19. Cassone A, De Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 1999;180:448-53
20. Kovacs A, Wasserman SW, Burns D, et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001;358:1593-601
21. Mostad SB, Overbaugh J, De Vange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from cervix and vagina. Lancet 1997;350:922-7
22. Spinillo A, Debiaggi M, Zara F, et al. Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions. Br J Obstet Gynaecol 2001;108:634-41
23. Wang CC, McClelland RS, Reilly M, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001;183:1017-22
24. Ghys PD, Fransen K, Diallo MO, et al. The association between cervico-vaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 1997;11:F83-5
25. Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997;176:766-70
26. Nkengasong JN, Kestens L, Ghys PD, et al. Human Immunodeficiency Virus Type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with Sexually Transmitted Disease in Abidjan, Cote d'Ivôre. J Infect Dis 2001;183:1405-8